| |
| |
|
| Insider
Information: |
Siu Christine |
| Relationship: |
CFO and Secretary |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
36,470 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$4,456,999 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,470 |
|
|
| Total
Value |
$4,456,999 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eidos Therapeutics, Inc. |
EIDX |
CFO and Secretary |
2019-12-09 |
36,470 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-09 |
4 |
S |
$59.62 |
$596,570 |
D/D |
(10,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-09 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
46,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-04 |
4 |
S |
$58.60 |
$586,943 |
D/D |
(10,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-04 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
46,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-03 |
4 |
S |
$57.82 |
$591,608 |
D/D |
(10,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-12-03 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
46,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-11-22 |
4 |
S |
$54.71 |
$547,456 |
D/D |
(10,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-11-22 |
4 |
OE |
$0.59 |
$5,900 |
D/D |
10,000 |
46,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-11-21 |
4 |
S |
$55.12 |
$1,378,077 |
D/D |
(25,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-11-21 |
4 |
OE |
$0.59 |
$14,750 |
D/D |
25,000 |
61,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-07-10 |
4 |
S |
$39.37 |
$196,850 |
D/D |
(5,000) |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-07-10 |
4 |
OE |
$0.59 |
$2,950 |
D/D |
5,000 |
41,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-06-26 |
4 |
OE |
$0.59 |
$10,030 |
D/D |
17,000 |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-06-05 |
4 |
S |
$29.34 |
$509,487 |
D/D |
(17,000) |
19,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-05-31 |
4 |
A |
$12.01 |
$21,247 |
D/D |
1,769 |
36,470 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-03-19 |
4 |
S |
$19.66 |
$234,210 |
D/D |
(11,913) |
34,701 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2019-03-19 |
4 |
OE |
$0.15 |
$22,081 |
D/D |
45,533 |
46,614 |
0 |
- |
|
| EIDX |
Eidos Therapeutics, Inc. |
CFO and Secretary |
• – – |
2018-11-30 |
4 |
A |
$12.01 |
$12,983 |
D/D |
1,081 |
1,081 |
0 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
